Skip to main content
. Author manuscript; available in PMC: 2010 May 1.
Published in final edited form as: Pharmacol Biochem Behav. 2009 Jan 23;92(3):448–456. doi: 10.1016/j.pbb.2009.01.012

Figure 5.

Figure 5

Figure 5a depicts locomotor activity during the pre-exposure phase (PDs 9, 10 and 11) as a function of the preexposure treatment (ig or no-ig). Figure 5b represents locomotor activity at testing as a function of the prior experience with the testing environment (context or no-context) and ethanol treatment (0 or 2.5 g/kg). Vertical lines illustrate standard errors of the means.